Outcomes out immediately verify that the drug donanemab, hailed as a turning level within the struggle in opposition to Alzheimer’s, slows cognitive decline by a couple of third.
The antibody therapy helps within the early phases of the illness.
It really works in Alzheimer’s illness, not in different sorts of dementia, equivalent to vascular dementia.
That’s as a result of it’s designed to clear away one of many key options of Alzheimer’s illness – a substance known as amyloid that builds up within the areas between mind cells.
Please subscribe right here: http://bit.ly/1rbfUog
#Dementia #Alzheimers #BBCNews